Back

How to diagnose cardiotoxicity of anticancer treatment.

28 August 2021 (09:41 - 09:52)
Organised by:
Congress Presentation Part of: Cardiotoxicity of cancer therapy: a clinical update Cardiovascular Disease in Specific Populations Open Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Jose Luis Zamorano Gomez

Ramon and Cajal University Hospital, Madrid (Spain)

4 More presentations in this session

Presentation thumbnail
How to estimate risk for cardiotoxicity in clinical practice.
Doctor A. Lyon (London, GB)
Video
Presentation thumbnail
How to monitor cardiovascular toxicity of anticancer treatment.
Professor B. Popescu (Bucharest, RO)
Slides Video
Presentation thumbnail
Cardiotoxicity of cancer therapy: a clinical update – discussion.
Video
Presentation thumbnail
Cardiotoxicity of cancer therapy: a clinical update - Chat Moderator.

Access the full session

Session thumbnail
Cardiotoxicity of cancer therapy: a clinical update
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 09:41 CET
You may be interested in
thumbnail
Webinar
Council Webinar: How, when and why advanced cardiac echo is needed in cardio oncology?
27 January 2020
thumbnail
Congress Presentation
New target for chemotherapy-induced cardiac dysfunction
20 June 2025
thumbnail
Congress Presentation
Biomarkers' ability to predict cardiac toxicity in oncological patients undergoing to antineoplastic treatment: 5-year follow-up
28 August 2020
thumbnail
Congress Presentation
Incidence of cancer treatment-related cardiotoxicity in patients with lymphoma treated with non-pegylated liposomal doxorubicin
21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources